Developing new light-driven catalysts for making medicines
Organic Photoredox Catalysts for Synthetic Method Development
This study is looking at new ways to use light to help make medicines more safely and efficiently, without relying on expensive or harmful materials, which could lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-11012873 on NIH RePORTER |
What this research studies
This research focuses on creating innovative organic photoredox catalysts that utilize light to drive chemical reactions, which can lead to more efficient and sustainable methods for synthesizing medicines. By avoiding the use of precious metals and hazardous reagents, this approach aims to enhance the safety and effectiveness of chemical processes. The project seeks to explore new reaction pathways and improve the selectivity and efficiency of drug manufacturing, ultimately benefiting the pharmaceutical industry and patient care.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients who rely on medications that could be produced more efficiently and sustainably through advanced chemical processes.
Not a fit: Patients who do not require medications or treatments that involve complex chemical synthesis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more efficient methods for producing essential medicines.
How similar studies have performed: Previous research in photoredox catalysis has shown promising results, indicating that this approach could lead to significant advancements in chemical synthesis.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Miyake, Garret Morgan — Colorado State University
- Study coordinator: Miyake, Garret Morgan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.